1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
20.86%
Revenue growth above 1.5x OGI.TO's 7.91%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
30.04%
Gross profit growth at 50-75% of OGI.TO's 41.96%. Martin Whitman would question if cost structure or brand is lagging.
-72.06%
Negative EBIT growth while OGI.TO is at 72.24%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-130.61%
Negative operating income growth while OGI.TO is at 72.24%. Joel Greenblatt would press for urgent turnaround measures.
-61.23%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
100.00%
Positive EPS growth while OGI.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
100.00%
Positive diluted EPS growth while OGI.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-100.00%
Share reduction while OGI.TO is at 3.77%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-100.00%
Reduced diluted shares while OGI.TO is at 0.30%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-122.31%
Negative OCF growth while OGI.TO is at 188.19%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-232.20%
Negative FCF growth while OGI.TO is at 121.61%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-100.00%
Negative 10Y revenue/share CAGR while OGI.TO stands at 2946.30%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while OGI.TO stands at 28.61%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while OGI.TO stands at 7.37%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
10Y OCF/share CAGR under 50% of OGI.TO's 345.25%. Michael Burry would worry about a persistent underperformance in cash creation.
100.00%
Positive OCF/share growth while OGI.TO is negative. John Neff might see a comparative advantage in operational cash viability.
100.00%
3Y OCF/share CAGR under 50% of OGI.TO's 232.70%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
100.00%
Positive 10Y CAGR while OGI.TO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
100.00%
5Y net income/share CAGR similar to OGI.TO's 97.71%. Walter Schloss might see both on parallel mid-term trajectories.
100.00%
Positive short-term CAGR while OGI.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
-100.00%
Negative equity/share CAGR over 10 years while OGI.TO stands at 390.58%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-100.00%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-100.00%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.53%
AR growth well above OGI.TO's 15.12%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.84%
Inventory shrinking or stable vs. OGI.TO's 8.81%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-39.05%
Negative asset growth while OGI.TO invests at 4.97%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-100.00%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.41%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-60.00%
Our R&D shrinks while OGI.TO invests at 3.79%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
12.05%
SG&A growth well above OGI.TO's 9.96%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.